Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental ...

Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse model study, bringing researchers ...

A University of Florida study shows an mRNA vaccine combined with immunotherapy drugs significantly boosts the immune systems ...

A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

An experimental mRNA vaccine improved the tumor-fighting benefits of immunotherapy in a mouse model study, bringing researchers one step closer to their aim of generating a universal vaccination to ...

TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very ...